Besides, endogenous IL-33 release, within 24 h, after administration of alum-adjuvanted nasal influenza vaccine, induced higher IgA Ab production via enhancing Ag presentation on DCs and promoting ILC2 activation44. Here, CD79A is linked to influenza.